UK and U.S. look to stockpile more Roche flu drug

Key points
- Britain and the United States are discussing buying extra stockpiles of antiviral drug Tamiflu to protect against a potential bird flu pandemic, Switzerland's Roche Holding AG said on Monday.
- Industry sources in London said the British government could announce a major order for the drug as early as Tuesday.
- Roche's Tamiflu has been singled out by the World Health Organisation as its drug of choice to protect against bird flu and for use in case of a widespread human outbreak.
- It is not a cure, but can reduce symptoms and may prevent the spread of infection.
Britain and the United States are discussing buying extra stockpiles of antiviral drug Tamiflu to protect against a potential bird flu pandemic, Switzerland's Roche Holding AG said on Monday.
Industry sources in London said the British government could announce a major order for the drug as early as Tuesday.
Roche's Tamiflu has been singled out by the World Health Organisation as its drug of choice to protect against bird flu and for use in case of a widespread human outbreak.
It is not a cure, but can reduce symptoms and may prevent the spread of infection.
Pharmaceuticals head William Burns told reporters on the sidelines of the company's annual shareholder meeting that negotiations with British and U.S. officials were continuing.
"We are still in discussions with Britain and America," Burns said, adding that nothing formal had yet been heard from the British government.
People familiar with the situation said Britain was likely to announce the purchase of enough Tamiflu for one in four of the population - the maximum number the WHO predicts might be infected in an outbreak.
Governments around the world have been stockpiling the drug to combat a possible pandemic of bird flu, which has now killed 47 people in Asia.
Experts fear the virus could mutate into a form that can pass between humans and trigger a pandemic similar to one in 1918-19, which killed 20 million to 40 million people.
Roche has already increased Tamiflu production capacity to meet additional demand and plans to increase it again in 2005.
Ironically, revenues from Tamiflu proved disappointing in 2004, when a relatively mild influenza season meant overall demand declined from 2003, despite the stockpiling initiatives by various governments.
Tamiflu is an antiviral agent used to treat the flu (Influenza A and B) in patients who have had symptoms for no more than 2 days.
TAMIFLU (TAM-ih-flew) is a medicine to treat flu (infection caused by influenza virus). It belongs to a group of medicines called neuraminidase inhibitors. These medications attack the influenza virus and prevent it from spreading inside your body. TAMIFLU treats flu at its source by attacking the virus that causes the flu, rather than simply masking symptoms. Each TAMIFLU capsule (grey/light yellow) contains 75 mg of active drug and should be taken by mouth.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsPersonalized Strategies to Address Barriers to HIV Drug Adherence Boost Chances of Successful Therapy, Penn Medicine Study Shows
HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses…
30 January 2013
NewsDrug overdoses top AIDS as main cause of homeless deaths
Overdoses of drugs, particularly prescription pain-killers and heroin, have overtaken AIDS to become the leading cause of death of homeless adults, according to a study of homeless residents of Boston released on…
16 January 2013
NewsLooking Ahead to AIDS-Free Generation
2012 was a year when political leaders and top health officials freely spoke of attaining an AIDS-free generation. In November, Secretary of State Hillary Clinton unveiled a blueprint for achieving that goal. Secretary…
